$273 Million is the total value of Iguana Healthcare Management, LLC's 75 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 63.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CELG | Sell | CELGENE CORP | $17,516,000 | -26.9% | 175,000 | -12.5% | 6.42% | -18.6% |
| CI | Sell | CIGNA CORPORATION | $13,724,000 | -30.5% | 100,000 | -25.9% | 5.03% | -22.6% |
| BAX | Sell | BAXTER INTL INC | $11,913,000 | -3.9% | 290,000 | -10.8% | 4.36% | +7.0% |
| GILD | Sell | GILEAD SCIENCES INC | $7,808,000 | -14.3% | 85,000 | -5.6% | 2.86% | -4.5% |
| AMGN | Sell | AMGEN INC | $5,248,000 | -67.7% | 35,000 | -65.0% | 1.92% | -64.0% |
| MDRX | Sell | ALLSCRIPTS HEALTHCARE SOLUTN | $3,303,000 | -21.9% | 250,000 | -9.1% | 1.21% | -13.1% |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $2,033,000 | -52.3% | 250,000 | -29.2% | 0.74% | -46.8% |
| BKD | Sell | BROOKDALE SR LIVING INC | $1,985,000 | -28.3% | 125,000 | -16.7% | 0.73% | -20.2% |
| XLRN | Sell | ACCELERON PHARMA INC | $1,979,000 | -72.9% | 75,000 | -50.0% | 0.72% | -69.9% |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $1,796,000 | -52.2% | 125,000 | -28.6% | 0.66% | -46.8% |
| AGTC | Sell | APPLIED GENETIC TECHNOL CORP | $1,398,000 | -54.3% | 100,000 | -33.3% | 0.51% | -49.2% |
| CYTK | Sell | CYTOKINETICS INC | $1,234,000 | -66.3% | 175,000 | -50.0% | 0.45% | -62.5% |
| HTWR | Sell | HEARTWARE INTL INC | $943,000 | -73.3% | 30,000 | -57.1% | 0.35% | -70.2% |
| RXDX | Sell | IGNYTA INC | $846,000 | -60.5% | 125,000 | -21.9% | 0.31% | -56.0% |
| ARIA | Sell | ARIAD PHARMACEUTICALS INC | $639,000 | -48.9% | 100,000 | -50.0% | 0.23% | -43.1% |
| SGMO | Sell | SANGAMO BIOSCIENCES INC | $454,000 | -75.1% | 75,000 | -62.5% | 0.17% | -72.4% |
| AQXP | Exit | AQUINOX PHARMACEUTICALS INC | $0 | – | -25,000 | -100.0% | -0.10% | – |
| GENN | Exit | GENESIS HEALTHCARE INC | $0 | – | -100,000 | -100.0% | -0.11% | – |
| PPHM | Exit | PEREGRINE PHARMACEUTICALS IN | $0 | – | -500,000 | -100.0% | -0.19% | – |
| WOOF | Exit | VCA INC | $0 | – | -15,000 | -100.0% | -0.27% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -150,000 | -100.0% | -0.37% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -400,000 | -100.0% | -0.40% | – |
| Exit | ILLUMINA INCput | $0 | – | -7,500 | -100.0% | -0.47% | – | |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -75,000 | -100.0% | -0.54% | – |
| DEPO | Exit | DEPOMED INC | $0 | – | -100,000 | -100.0% | -0.60% | – |
| ZLTQ | Exit | ZELTIQ AESTHETICS INC | $0 | – | -75,000 | -100.0% | -0.70% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -35,000 | -100.0% | -0.71% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -150,000 | -100.0% | -0.73% | – |
| Exit | STRYKER CORPcall | $0 | – | -25,000 | -100.0% | -0.76% | – | |
| VRX | Exit | VALEANT PHARMACEUTICALS INTL | $0 | – | -25,000 | -100.0% | -0.84% | – |
| NVDQ | Exit | NOVADAQ TECHNOLOGIES INC | $0 | – | -200,000 | -100.0% | -0.84% | – |
| Exit | ZIMMER BIOMET HLDGS INCcall | $0 | – | -25,000 | -100.0% | -0.84% | – | |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.96% | – |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -110,000 | -100.0% | -0.98% | – |
| EVHC | Exit | ENVISION HEALTHCARE HLDGS IN | $0 | – | -125,000 | -100.0% | -1.07% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -1.26% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -1.27% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -60,687 | -100.0% | -1.39% | – |
| ENDP | Exit | ENDO INTL PLC | $0 | – | -75,000 | -100.0% | -1.51% | – |
| ESRX | Exit | EXPRESS SCRIPTS HLDG CO | $0 | – | -60,000 | -100.0% | -1.73% | – |
| AET | Exit | AETNA INC NEW | $0 | – | -50,000 | -100.0% | -1.78% | – |
| TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDadr | $0 | – | -150,000 | -100.0% | -3.24% | – |
| MYL | Exit | MYLAN N V | $0 | – | -225,000 | -100.0% | -4.00% | – |
| Exit | SELECT SECTOR SPDR TRput | $0 | – | -500,000 | -100.0% | -11.85% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2016-05-24
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 17 | Q1 2018 | 7.5% |
| ULTRAGENYX PHARMACEUTICAL IN | 17 | Q1 2018 | 6.7% |
| MERCK & CO INC NEW | 16 | Q1 2018 | 5.4% |
| CELGENE CORP | 15 | Q4 2017 | 7.9% |
| AERIE PHARMACEUTICALS INC | 15 | Q4 2017 | 3.3% |
| GILEAD SCIENCES INC | 14 | Q1 2017 | 6.7% |
| ESPERION THERAPEUTICS INC NE | 14 | Q1 2018 | 7.8% |
| SUPERNUS PHARMACEUTICALS INC | 14 | Q4 2017 | 2.8% |
| DERMIRA INC | 14 | Q1 2018 | 2.7% |
| AMGEN INC | 13 | Q1 2017 | 6.5% |
View Iguana Healthcare Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-05-15 |
| 13F-HR | 2018-02-14 |
| 13F-HR/A | 2017-11-16 |
| 13F-HR | 2017-11-14 |
| 13F-HR | 2017-08-14 |
| 13F-HR | 2017-05-15 |
| 13F-HR | 2017-02-14 |
| 13F-HR/A | 2016-11-17 |
| 13F-HR | 2016-11-14 |
| 13F-HR/A | 2016-11-04 |
View Iguana Healthcare Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.